Evaluating Organ Systems in Lupus
LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.
Anifrolumab for Lupus
Anifrolumab, a type 1 interferon receptor antagonist, performs well in early trial, researchers show.
When the Patient Insists on Natural Therapies
Patients sometimes insist on non-traditional therapies after a rheumatoid arthritis diagnosis. Their concerns shouldn't be ignored and instead, patients should be counseled on therapeutic options.
Prompting Medical Students to Choose Rheumatology
Facing a growing shortage, rheumatology is looking to attract the next generation of providers.
International Medical School Students Filling the Rheumatologist Shortage
Retaining international medical students, addressing student loan debt, mentoring and case-based teaching could possibly reverse the rheumatologist shortage, analysis says.
Q&A: Periodontal Disease and Rheumatoid Arthritis
In this Q&A we feature a conversation with Felipe Andrade, M.D., Ph.D., of the Johns Hopkins University School of Medicine in Baltimore.
PsA Treatment Guidelines Organized by Five Domains
The 2015 recommendations for PsA treatment highlight the importance of managing comorbidities and a patient-centered treatment approach.
By clicking Accept, you agree to become a member of the UBM Medica Community.